Homocysteine

Inflammatory

Cardiovascular Inflammation

Homocysteine is an amino acid intermediate that the body normally recycles using B vitamins and healthy methylation. When that pathway falters, homocysteine accumulates and can damage the endothelial lining of blood vessels. A longevity practice measures it because it links nutrition, genetics, and vascular and brain aging in a single, correctable marker.

What It Measures

Amino acid intermediate; elevated levels damage endothelium, promote clotting, and increase cardiovascular, stroke, and dementia risk

Optimal vs. Lab Range

Longevity Optimal

<8 µmol/L

Target range for optimal health and longevity based on research.

Standard Lab

5–15 µmol/L

Population-based reference range from standard labs.

Why It Matters

Elevated homocysteine damages the endothelium, promotes clotting, and is associated with higher cardiovascular, stroke, and dementia risk, making it especially relevant to healthspan and cognitive aging. High values often reflect B12, folate, or B6 deficiency, MTHFR gene variants, kidney disease, or hypothyroidism, so the marker frequently points to an identifiable and modifiable cause. It also carries relevance in reproductive health, where elevation is linked to neural tube defects. Because it sits at the crossroads of methylation and vascular biology, homocysteine is a favored longevity target. Lower levels are generally favorable.

When Low

Generally favorable when low

When High

B12/folate/B6 deficiency, MTHFR mutations, kidney disease, hypothyroidism; cardiovascular disease, stroke, Alzheimer risk, neural tube defects

How to Optimize

The most direct lever is supporting the B-vitamin methylation pathway, typically with methylfolate, methyl-B12, and B6, with methylfolate especially relevant if you carry an MTHFR variant. Trimethylglycine (TMG) can provide an additional methyl donor to help clear homocysteine. Because kidney and thyroid function also influence levels, your physician may investigate these when values stay high. Retesting after starting supplementation confirms whether the pathway is responding. Targets and treatment are individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Strong evidence

Key Interventions

Methylfolate (if MTHFR+)

methyl-B12

TMG (trimethylglycine)

Linked Compounds & Supplements

Methylfolate

Methyl-B12

B6 (P-5-P)

TMG

NAC

Riboflavin

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum or plasma (venous draw)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Semi-annual

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Homocysteine.
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.